Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Karyopharm Therapeutics Inc (KPTI)
Karyopharm Therapeutics Inc (KPTI) Financials

KPTI Karyopharm Therapeutics Inc

0.945

-0.075 (-7.35%)

15 Jun 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-55.366	-71.523	-68.423	-62.749	-64.562	-40.135	-49.826	-47.81
Return on Equity (%)	-60.773	-88.434	-114.132	-171.363	-391.294	852.048	343.18	187.226
Return on Invested Capital (%)	-79.099	-120.866	-93.973	-86.049	-114.606	-92.518	-128.272	-139.717
Operating Margin (%)	-71063.636	-8032.461	-579.8	-449.718	-156.196	-46.599	-89.083	-81.456
Net Profit Margin (%)	-71153.896	-8036.386	-588.103	-488.079	-181.591	-59.14	-105.231	-97.991
Book Value Per Share	3.873	2.614	3.011	0.761	0.684	-1.052	-0.147	-1.189
Earnings Per Share	-2.616	-2.604	-2.933	-3.053	-2.655	-1.638	-1.46	-1.249
Cash Per Share	1.186	1.393	1.94	1.971	1.162	2.514	1.194	0.456
Working Capital Per Share	2.749	1.998	4.73	3.552	2.926	2.665	2.511	1.436
Operating Profit Per Share	0.004	0.032	0.499	0.589	1.426	2.725	1.341	1.232
EBIT Per Share	-2.613	-2.603	-2.932	-3.053	-2.651	-1.635	-1.457	-1.247
EBITDA Per Share	-2.613	-2.603	-2.932	-3.053	-2.651	-1.635	-1.457	-1.247
Free Cash Flow Per Share	-2.631	-2.617	-2.906	-3.065	-2.666	-1.646	-1.464	-1.254

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	7.99	3	7.134	6.01	4.593	3.739	5.313	3.367
Quick Ratio	7.863	2.965	6.997	5.845	4.395	3.493	4.948	3.153
Inventory Turnover (Days)	N/A	N/A	N/A	3.088	8.929	7.143	9.816	7.606
Shares Outstanding	41.89M	49.53M	60.83M	65.37M	73.92M	75.75M	113.21M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	79.42M	79.8M	81.03M	113.21M	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	-72.551	N/A	N/A	N/A	-73.167	N/A	N/A	N/A
Net Profit Margin (%)	-86.845	N/A	N/A	N/A	-88.185	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	4.169	N/A	N/A	N/A	5.175	N/A	N/A	N/A
Quick Ratio	3.487	N/A	N/A	N/A	4.816	N/A	N/A	N/A
Inventory Turnover (Days)	29.662	N/A	N/A	N/A	36.096	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	109.31M
Price to Earnings Ratio	-0.76
Price to Sales Ratio	0.75
Price to Cash Ratio	2.09
Price to Book Ratio	-0.8
Dividend Yield	-

Share Statistics

Shares Outstanding	115.07M
Average Volume (1 week)	1.1M
Average Volume (1 Month)	1.28M
52 Week Change	-56.65%
52 Week High	2.33
52 Week Low	0.6174

More Ratios Coming Soon!

Karyopharm Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions